Søk Finn patenter, varemerker og design i Norge Nøkkelinformasjon Databasen er sist oppdatert Tittel Status Hovedstatus Detaljstatus Patentnummer Europeisk (EP) publiserings nummer 2017.02.11 11:59:00 Fremgangsmåte for lindring av bivirkninger av retinsyreterapi og/eller forbedring av effekten uten å hindre effekten I kraft 2014.06.23 EP patent gjort gjeldende i Norge 2014.06.23 EP patent besluttet gjeldende i Norge NO/EP2120917 EP2120917 EP inngitt 2008.02.27 EP søknadsnummer 08726182.2 EP meddelt 2014.01.22 Prioritet Sakstype 2007.02.28, 903937 P Europeisk Løpedag 2008.02.27 Utløpsdato 2028.02.27 Allment tilgjengelig 2009.11.25 Meddelt 2014.06.23 Innehaver Oppfinner Fullmektig Lenke til European patent Register Patentfamilie University Of Kentucky Research Foundation () JACOBSON, Elaine, L. () Zacco Norway AS (NO) Informasjon i saken, dokumenter og patentfamilie Se i Espacenet Sammendrag og figur Se forsidefigur og sammendrag i Espacenet Klasser IPC-klasse A61K 31/21 A61K 8/36 A61K 8/49 A61K 8/67 A61K 31/203 A61K 31/455 A61P 17/00 A61Q 17/00 A61Q 19/00
Søker Innehaver Europeisk innehaver: University Of Kentucky Research Foundation 207 Administration Building Lexington KY 40506-0032 Arizona Board of Regents on behalf of the University of Arizona 888 North Euclid Avenue Tucson, AZ 85721-0158 Oppfinner JACOBSON, Elaine, L. JACOBSON, Myron, K. COYLE, Russell KIM, Hyuntae Arizona Board Of Regents on behalf of The University of Arizona;888 North Euclid Avenue Tucson, AZ 85721-0158 COYLE, Donna, L. Niadyne Inc., 1601 N.Tuscon Blvd., Suite 7 Tuscon, Arizona 85716 Fullmektig Zacco Norway AS Se mer Postboks 2003 Vika 0125 OSLO NO ( OSLO kommune, OSLO fylke ) Org.nummer: 982702887 Referanse på sak: P61400921NO00E Europeisk fullmektig: Gervasi, Gemma Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9 20122 Milano IT
Prioritet 2007.02.28, 903937 P Anførte dokumenter TASHTOH BASSAM M ET AL: "Analysis and stability study of myristyl nicotinate in dermatological preparations by highperformance liquid chromatography", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 43, no. 3, 16 October 2006 (2006-10-16), pages 893-899, XP005870889, ISSN: 0731-708 (B1/EP) JACOBSON E L ET AL: "A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin", EXPERIMENTAL DERMATOLOGY 200706 GB LNKD- DOI:10.1111/J.1600-0625.2007.00553.X, vol. 16, no. 6, June 2007 (2007-06), pages 490-499, XP000002656461, ISSN: 0906-6705 (B1/EP) JACOBSON M K ET AL: "Enhancement of human skin barrier integrity by nicotinic acid derivatives", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 122, no. 3, March 2004 (2004-03), page A58, XP000002656462, & THE 65TH ANNUAL MEETING OF THE SOCIETY FOR INVESTIGATIVE DERMATOLOGY; PROVIDENCE, RHODE ISLAND, A; APRIL 28-MAY 01, 2004 ISSN: 0022-202X (B1/EP) TAGAMI H ET AL: "Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea pigs and humans: Comparison with topical retinoic acid treatment", BRITISH JOURNAL OF DERMATOLOGY, vol. 127, no. 5, 1992, pages 470-475, XP000002656463, ISSN: 0007-0963 (B1/EP) -A1-2002 128 298 (B1/EP) -A1-2002 137 693 (B1/EP) -A1-2007 009 474 (B1/EP) -B2-6 677 361 (B1/EP) -A1-2004 147 491 (B1/EP) RENDL M. ET AL.: 'Caspase-14 Expression by Epidermal Keratinocytes is Regulated by Retinoids in a Differentiation-associated Manner' J. OF INVEST. DERMATOL. vol. 119, 2002, pages 1150-1152, XP008112068 (B1/EP) JACOBSON M K ET AL: "Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage", EXPERIMENTAL DERMATOLOGY 200711 GB LNKD- DOI:10.1111/J.1600-0625.2007.00616.X, vol. 16, no. 11, November 2007 (2007-11), pages 927-935, XP000002656464, ISSN: 0906-6705 (B1/EP) JACOBSON M K ET AL: "Myristyl nicotinate mitigates skin barrier impairment and improves tolerability of retinoic acid therapy", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 127, no. Suppl. 1, April 2007 (2007-04), page S51, XP000002656465, & 68TH ANNUAL MEETING OF THE SOCIETY-FOR-INVESTIGATIVE-DERMATOLOGY; LOS ANGELES, CA, A; MAY 09-12, 2007 ISSN: 0022-202X (B1/EP) TASHTOH B M ET AL: "Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier", DRUG DEVELOPMENT AND INDTRIAL PHARMACY 200711 LNKD- DOI:10.1080/03639040701199274, vol. 33, no. 11, November 2007 (2007-11), pages 1176-1182, XP008140599, ISSN: 0363-9045 (B1/EP) JACOBSON E L ET AL: "A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin", EXPERIMENTAL DERMATOLOGY 200706 GB LNKD- DOI:10.1111/J.1600-0625.2007.00553.X, vol. 16, no. 6, June 2007 (2007-06), pages 490-499, XP000002656461, ISSN: 0906-6705 (B1) JACOBSON M K ET AL: "Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage", EXPERIMENTAL DERMATOLOGY 200711 GB LNKD- DOI:10.1111/J.1600-0625.2007.00616.X, vol. 16, no. 11, November 2007 (2007-11), pages 927-935, XP000002656464, ISSN: 0906-6705 (B1) JACOBSON M K ET AL: "Enhancement of human skin barrier integrity by nicotinic acid derivatives", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 122, no. 3, March 2004 (2004-03), page A58, XP000002656462, & THE 65TH ANNUAL MEETING OF THE SOCIETY FOR INVESTIGATIVE DERMATOLOGY; PROVIDENCE, RHODE ISLAND, A; APRIL 28-MAY 01, 2004 ISSN: 0022-202X (B1) JACOBSON M K ET AL: "Myristyl nicotinate mitigates skin barrier impairment and improves tolerability of retinoic acid therapy", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 127, no. Suppl. 1, April 2007 (2007-04), page S51, XP000002656465, & 68TH ANNUAL MEETING OF THE SOCIETY-FOR-INVESTIGATIVE-DERMATOLOGY; LOS ANGELES, CA, A; MAY 09-12, 2007 ISSN: 0022-202X (B1) RENDL M. ET AL.: 'Caspase-14 Expression by Epidermal Keratinocytes is Regulated by Retinoids in a Differentiation-associated Manner' J. OF INVEST. DERMATOL. vol. 119, 2002, pages 1150-1152, XP008112068 (B1) TAGAMI H ET AL: "Functional assessment of the stratum corneum under the influence of oral aromatic retinoid (etretinate) in guinea pigs and humans: Comparison with topical retinoic acid treatment", BRITISH JOURNAL OF DERMATOLOGY, vol. 127, no. 5, 1992, pages 470-475, XP000002656463, ISSN: 0007-0963 (B1) -B2-6 677 361 (B1) TASHTOH BASSAM M ET AL: "Analysis and stability study of myristyl nicotinate in dermatological preparations by highperformance liquid chromatography", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, vol. 43, no. 3, 16 October 2006 (2006-10-16), pages 893-899, XP005870889, ISSN: 0731-7085 (B1) -A1-2002 128 298 (B1) -A1-2002 137 693 (B1) -A1-2004 147 491 (B1) -A1-2007 009 474 (B1) TASHTOH B M ET AL: "Formulation compatibility of myristyl nicotinate with drugs used to treat dermatological conditions involving an impaired skin barrier", DRUG DEVELOPMENT AND INDTRIAL PHARMACY 200711 LNKD- DOI:10.1080/03639040701199274, vol. 33, no. 11, November 2007 (2007-11), pages 1176-1182, XP008140599, ISSN: 0363-
9045 (B1) Lisens Pant Klage til Klagenemnda Administrativ prøving Innsigelse Protest / Oppreisning Sakshistorikk Statushistorie Hovedstatus Beslutningsdato, detaljstatus 2014.06.23 EP patent gjort gjeldende i Norge 2014.06.23 EP patent besluttet gjeldende i Norge 2014.04.15 EP under behandling 2014.04.23 Forespørsel om å gjøre EP patent gyldig er mottatt Korrespondanse Dato Type korrespondanse Journal beskrivelse 2016.08.17 Innkommende EP Publiseringsdokument fra EPO 2016.03.23 Innkommende EP Publiseringsdokument fra EPO 2015.06.10 Innkommende EP Publiseringsdokument fra EPO 2014.12.31 Innkommende EP Publiseringsdokument fra EPO 2014.12.10 Innkommende EP Publiseringsdokument fra EPO 2014.11.26 Innkommende EP Publiseringsdokument fra EPO 2014.11.12 Innkommende EP Publiseringsdokument fra EPO 2014.10.08 Innkommende EP Publiseringsdokument fra EPO 2014.09.10 Innkommende EP Publiseringsdokument fra EPO 2014.09.03 Innkommende EP Publiseringsdokument fra EPO 2014.07.03 Utgående EP Registreringsbrev 2014.04.23 Innkommende Hovedbrev E-post 2014.04.15 Innkommende Søknadsskjema Patent 2014.01.22 Innkommende EP Publiseringsdokument fra EPO Informasjon om ikke tilgjengelige dokumenter Betaling Til betaling:
Beskrivelse Forfallsdato Beløp Status Årsavgift 2017.02.28 Ikke betalt Årsavgift 10. avg. år (EP) 3200 Totalbeløp 3200 Betalingshistorikk: Beskrivelse / Fakturanummer Betalingsdato Beløp Betaler Status Årsavgift 9. avg. år (EP) 2016.02.26 2850 Computer Årsavgift 8. avg. år (EP) 2015.02.26 2550 Computer 31405909 2014.05.14 1200 Zacco Norway AS Årsavgift 7. avg. år (EP) 2014.02.27 2000 Computer Betalt Denne oversikten kan mangle informasjon, spesielt for eldre saker, internasjonale varemerker og internasjonale design. Publikasjon(er) Lenker til publikasjoner og Norsk Patenttidende (søkbare tekstdokumenter) Oversettelse av europeisk patentskrift Norsk Patenttidende (ved meddelelse) Lenker til publikasjoner (ikke søkbare tekstdokumenter) B1/EP Hva betyr A1, B, B1, C osv?